Healthcare Trust of America, Inc. Reports 2019 Results And 2020 Earnings Guidance

Start generating passive income through real estate.

Own a piece of your favorite cities through diversified real estate investments in the country's top markets

*Terms and conditions apply. Visit Nada's website for more details.

SCOTTSDALE, Ariz., Feb. 13, 2020 /PRNewswire/ -- Healthcare Trust of America, Inc. HTA ("HTA") announced results for the quarter and year ended December 31, 2019.

Healthcare Trust of America, Inc. Logo. (PRNewsFoto/Healthcare Trust of America, Inc.) (PRNewsfoto/Healthcare Trust of America, In)

"In 2019, HTA grew its best-in-class portfolio with strategic accretive investments in key markets, while continuing to build strong tenant and health system relationships and strategic partnerships," stated Chairman, CEO and President Scott D. Peters.  "As we continue to be the leader in the medical office building ("MOB") industry, HTA will look ahead in 2020 for innovative ways to grow as a company and continue to provide attractive returns for our stockholders."

Highlights

Fourth Quarter 2019:

  • Net income Attributable to Common Stockholders was $8.9 million, or $0.04 per diluted share, a decrease of $(0.03) per diluted share, compared to 2018.
  • Funds From Operations ("FFO"), as defined by the National Association of Real Estate Investment Trusts ("NAREIT"), was $87.3 million, or $0.41 per diluted share, for Q4 2019. Due to the adoption of Topic 842, certain initial direct costs are now reported in general and administrative expenses. For Q4 2018, HTA capitalized approximately $1.2 million of initial direct costs.
  • Normalized FFO was $88.9 million, or $0.42 per diluted share, for Q4 2019, an increase of $0.02, or 5.0%, per diluted share, compared to 2018.
  • Normalized Funds Available for Distribution ("FAD") was $72.3 million for Q4 2019.
  • Same-Property Cash Net Operating Income ("NOI") increased $2.8 million, or 2.5%, to $114.9 million, compared to Q4 2018. This included same-property rental revenue growth of 1.4%.
  • Leasing: HTA's portfolio had a leased rate of 90.8% by gross leasable area ("GLA") and an occupancy rate of 89.9% by GLA for Q4 2019. During Q4 2019, HTA executed approximately 1.0 million square feet of GLA of new and renewal leases. Re-leasing spreads increased to 3.4% and tenant retention for the Same-Property portfolio was 76% by GLA for Q4 2019.

Year Ended 2019:

  • Net Income Attributable to Common Stockholders was $30.2 million, or $0.14 per diluted share, a decrease of $(0.88) per diluted share, compared to 2018.
  • FFO, as defined by NAREIT, was $319.7 million, or $1.53 per diluted share, for 2019 and includes a $21.6 million, or $(0.10) per diluted share, loss related to the extinguishment of debt. For 2018, HTA capitalized approximately $4.9 million of initial direct costs.
  • Normalized FFO was $344.3 million, or $1.64 per diluted share, for 2019, an increase of $0.02, or 1.2%, per diluted share, compared to 2018.
  • Normalized FAD was $289.4 million for 2019.
  • Same-Property Cash NOI increased $12.1 million, or 2.7%, to $450.9 million, compared to 2018. This included same-property rental revenue growth of 2.3%.
  • Leasing: During the year ended December 31, 2019, HTA executed approximately 3.6 million square feet of GLA of new and renewal leases, or over 14.6% of the total GLA of its portfolio. Re-leasing spreads increased to 3.5% and tenant retention for the Same-Property portfolio was 83% by GLA year-to-date.

Balance Sheet and Capital Markets

  • Balance Sheet: HTA ended Q4 2019 with total liquidity of $1.2 billion, inclusive of $900.0 million available on our unsecured revolving credit facility, $306.2 million of unsettled equity sold under forward agreements, and $32.7 million of cash and cash equivalents. HTA also had total leverage of (i) 28.9%, measured as debt less cash and cash equivalents to total capitalization, and (ii) debt less cash and cash equivalents to Adjusted Earnings before Interest, Taxes, Depreciation and Amortization for real estate ("Adjusted EBITDAre") of 5.7x. Including the impact of the remaining forward equity to be settled, leverage would be 25% and 5.0x, respectively, using the definitions from above.
  • Equity: During 2019, HTA issued a total of $637.6 million in equity, comprised of approximately 21.6 million shares of common stock under its at-the-market ("ATM") offering program on a forward basis at an average price of $29.59, of which, $584.9 million comprised of 19.7 million shares were issued in Q4 2019 at an average price of $29.68. During 2019, HTA received net proceeds of $323.4 million on 11.1 million shares that settled, of which net proceeds of $271.6 million for 9.3 million shares were attributable to Q4 2019 settlements. Accordingly, we have approximately 10.5 million shares expected to settle in 2020 for net proceeds of $306.2 million, subject to adjustment for costs to borrow under the terms of the applicable equity distribution agreements.
  • Debt: In 2019, Healthcare Trust of America Holdings, LP ("HTALP") and HTA completed two transactions:
    • issued $900.0 million in senior, unsecured notes with a weighted average interest rate of 3.04% per annum and a weighted maturity of 9.5 years and used the net proceeds from the issuance to redeem $700.0 million worth of senior notes and to pay down the unsecured revolving credit facility. As part of these repayments, HTA incurred debt extinguishment costs of approximately $21.6 million; and
    • hedged $500 million of HTALP and HTA's term loans at 2.44% which effectively fixed the interests rates of the entire portfolio of the Company, except for the revolving credit facility.

Noteworthy 2019 Activities

  • Investments: In the quarter, HTA closed on $330 million of investments totaling approximately 1.1 million square feet of GLA. For the year, HTA has now closed $558 million of investments totaling approximately 1.6 million square feet of GLA, with expected year-one contractual yields of approximately 6.1%, after operating synergies. These properties were approximately 93% occupied as of closing, and are located within HTA's key markets. Over 55% of these properties are located on or adjacent to hospital campuses, and, all were acquired on a fee-simple basis.
  • Development/Redevelopment: As of December 31, 2019, HTA had the following development and redevelopment projects in place:
    • Developments: During 2019, HTA announced agreements to develop two new on-campus MOBs located in the key markets of Dallas, Texas and Bakersfield, California with anticipated costs of approximately $90 million totaling approximately 191,000 square feet of GLA. The new development projects have anticipated yields of over 6.5%. In total, HTA now has development projects of approximately $112 million totaling approximately 242,000 square feet of GLA and are expected to be more than 72% pre-leased upon completion.
    • Redevelopments: During 2019, HTA announced plans to redevelop two MOBs located in Los Angeles, California with estimated costs of approximately $20 million totaling approximately 105,000 square feet of GLA. In total, HTA's redevelopment projects have anticipated costs of approximately $64 million, covering approximately 230,000 square feet of GLA.
  • Dividends: On February 13, 2020, HTA's Board of Directors announced a quarterly cash dividend of $0.315 per share of common stock and per OP Unit. The quarterly dividend is to be paid on April 9, 2020 to stockholders of record of its common stock and holders of its OP Units on April 2, 2020.

Impact of Topic 842 Leases

  • The Financial Accounting Standards Board issued Topic 842, which was effective for HTA as of January 1, 2019. Topic 842 modifies the treatment of initial direct costs, which historically under Topic 840 were capitalized in accordance with certain criteria provided for in the applicable guidance. Topic 842 also eliminates the accounting recognition of expenses paid directly by tenants and moves certain bad debt costs from expense to revenue. During the quarter and year ended 2018, HTA capitalized $1.2 million and $4.9 million, respectively, of initial direct costs, certain of which, would now be expensed under Topic 842. In addition, for the quarter and year ended 2018, HTA recognized $3.4 million and $13.9 million, respectively, of tenant paid property taxes in both revenues and expenses and a nominal amount of bad debt costs recognized as expenses.

2020 Guidance

HTA expects 2020 guidance to range as follows:





Annual Expectations





Low

to

High

Net income attributable to common stockholders per share



$0.32



$0.36











Same-Property Cash NOI



2.0%



3.0%











FFO per share, as defined by NAREIT



$1.68



$1.71











Normalized FFO per share



$1.69



$1.73

The 2020 outlook guidance includes the following additional assumptions: (i) $500 - $600 million of investments at a 5.5% to 6.25% yield; (ii) $50 million of dispositions at a 6.0% average yield; (iii) general and administrative costs of $44 - $46 million, and (iv) approximately 226 million diluted, common shares outstanding.  HTA expects leverage, measured as (i) debt less cash and cash equivalents to total capitalization, and (ii) measured as debt less cash and cash equivalents to Adjusted EBITDAre to remain stable year-over-year.

HTA's 2020 guidance is based on a number of various assumptions that are subject to change and many of which are outside the control of the Company.  Additionally, HTA's guidance does not contemplate impacts from gains or losses from dispositions, potential impairments, or debt extinguishment costs, if any.  If actual results vary from these assumptions, HTA's expectations may change.  There can be no assurance that HTA will achieve these results.

About Healthcare Trust of America, Inc.

Healthcare Trust of America, Inc. HTA is the largest dedicated owner and operator of MOBs in the United States, comprising approximately 24.8 million square feet of GLA, with $7.3 billion invested primarily in MOBs.  HTA provides real estate infrastructure for the integrated delivery of healthcare services in highly-desirable locations.  Investments are targeted to build critical mass in 20 to 25 leading gateway markets that generally have leading university and medical institutions, which translates to superior demographics, high-quality graduates, intellectual talent and job growth.  The strategic markets HTA invests in support a strong, long-term demand for quality medical office space.  HTA utilizes an integrated asset management platform consisting of on-site leasing, property management, engineering and building services, and development capabilities to create complete, state of the art facilities in each market.  This drives efficiencies, strong tenant and health system relationships, and strategic partnerships that result in high levels of tenant retention, rental growth and long-term value creation.  Headquartered in Scottsdale, Arizona, HTA has developed a national brand with dedicated relationships at the local level.

Founded in 2006 and listed on the New York Stock Exchange in 2012, HTA has produced attractive returns for its stockholders that have outperformed the S&P 500 and US REIT index.  More information about HTA can be found on the Company's Website (www.htareit.com), Facebook, LinkedIn and Twitter.

Forward-Looking Language

This press release contains certain forward-looking statements with respect to HTA.  Forward-looking statements are statements that are not descriptions of historical facts and include statements regarding management's intentions, beliefs, expectations, plans or predictions of the future, within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Because such statements include risks, uncertainties and contingencies, actual results may differ materially and in adverse ways from those expressed or implied by such forward-looking statements.  These risks, uncertainties and contingencies include, without limitation, the following: changes in economic conditions generally and the real estate market specifically; legislative and regulatory changes, including changes to laws governing the taxation of REITs and changes to laws governing the healthcare industry; the availability of capital; changes in interest rates; competition in the real estate industry; the supply and demand for operating properties in our proposed market areas; changes in accounting principles generally accepted in the United States of America; policies and guidelines applicable to REITs; the availability of properties to acquire; and the availability of financing.  Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in our 2019 Annual Report on Form 10-K and in our filings with the SEC.

Conference Call

HTA will host a conference call and webcast on Friday, February 14, 2020 at 12:00 p.m. Eastern Time (10:00 a.m. Mountain Time) to review its financial performance and operating results for the quarter and year ended December 31, 2019.

Conference Call and Webcast Details:

Domestic Dial-In Number: (877) 507-6265

International Dial-In Number: (412) 902-6633

Canada Dial-In Number: (855) 669-9657

Webcast: www.htareit.com under the Investor Relations tab

Replay Conference Call Details:

Domestic Dial-In Number: (877) 344-7529

International Dial-In Number: (412) 317-0088

Canada Dial-In Number: (855) 669-9658

Conference ID: 10139033

Available February 14, 2020 (one hour after the end of the conference call) to March 14, 2020 at 12:00 p.m. Eastern Time (10:00 a.m. Mountain Time)

Financial Contact:

Robert A. Milligan

Chief Financial Officer

480.998.3478

HEALTHCARE TRUST OF AMERICA, INC.

CONSOLIDATED BALANCE SHEETS

(Unaudited and in thousands, except for share and per share data)













Year Ended December 31,





2019



2018

ASSETS









Real estate investments:









Land



$

584,546





$

481,871



Building and improvements



6,252,854





5,787,152



Lease intangibles



628,066





599,864



Construction in progress



28,150





4,903







7,493,616





6,873,790



Accumulated depreciation and amortization



(1,447,815)





(1,208,169)



Real estate investments, net



6,045,801





5,665,621



Investment in unconsolidated joint venture



65,888





67,172



Cash and cash equivalents



32,713





126,221



Restricted cash



4,903





7,309



Receivables and other assets, net



237,024





223,415



Right-of-use assets - operating leases, net



239,867







Other intangibles, net



12,553





98,738



Total assets



$

6,638,749





$

6,188,476



LIABILITIES AND EQUITY









Liabilities:









Debt



$

2,749,775





$

2,541,232



Accounts payable and accrued liabilities



171,698





185,073



Security deposits, prepaid rent and other liabilities



49,203





59,567



Lease liabilities - operating leases



198,650







Intangible liabilities, net



38,779





61,146



Total liabilities



3,208,105





2,847,018



Commitments and contingencies









Redeemable noncontrolling interests







6,544



Equity:









Preferred stock, $0.01 par value; 200,000,000 shares authorized; none issued and outstanding









Class A common stock, $0.01 par value; 1,000,000,000 shares authorized; 216,453,312 and 205,267,349 shares issued and outstanding as of December 31, 2019 and 2018, respectively



2,165





2,053



Additional paid-in capital



4,854,042





4,525,969



Accumulated other comprehensive income



4,546





307



Cumulative dividends in excess of earnings



(1,502,744)





(1,272,305)



Total stockholders' equity



3,358,009





3,256,024



Noncontrolling interests



72,635





78,890



Total equity



3,430,644





3,334,914



Total liabilities and equity



$

6,638,749





$

6,188,476



 

HEALTHCARE TRUST OF AMERICA, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited and in thousands, except per share data)













Three Months Ended December 31,



Year Ended December 31,



2019



2018



2019



2018

Revenues:















Rental income

$

176,199





$

172,204





$

691,527





$

696,030



Interest and other operating income

114





94





513





396



Total revenues

176,313





172,298





692,040





696,426



Expenses:















Rental

53,266





55,253





211,479





220,617



General and administrative

10,203





8,915





41,360





35,196



Transaction

1,492





70





2,350





1,003



Depreciation and amortization

78,654





69,566





290,384





279,630



Interest expense

24,031





24,457





96,632





101,849



Impairment













8,887



Total expenses

167,646





158,261





642,205





647,182



(Loss) gain on sale of real estate, net

(117)





(395)





(154)





165,977



Gain (loss) on extinguishment of debt, net





1,334





(21,646)





242



Income from unconsolidated joint venture

426





330





1,882





1,735



Other income

60





299





841





428



Net income

$

9,036





$

15,605





$

30,758





$

217,626



Net income attributable to noncontrolling interests

(118)





(276)





(604)





(4,163)



Net income attributable to common stockholders

$

8,918





$

15,329





$

30,154





$

213,463



Earnings per common share - basic:















Net income attributable to common stockholders

$

0.04





$

0.07





$

0.15





$

1.04



Earnings per common share - diluted:















Net income attributable to common stockholders

$

0.04





$

0.07





$

0.14





$

1.02



Weighted average common shares outstanding:















Basic

207,395





206,409





205,720





206,065



Diluted

211,472





210,338





209,605





210,061



Dividends declared per common share

$

0.315





$

0.310





$

1.250





$

1.230



 

HEALTHCARE TRUST OF AMERICA, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited and in thousands)





Year Ended December 31,



2019



2018



2017

Cash flows from operating activities:











Net income

$

30,758





$

217,626





$

65,577



Adjustments to reconcile net income to net cash provided by operating activities:











Depreciation and amortization

280,969





271,441





239,044



Share-based compensation expense

10,127





9,755





6,870



Impairment





8,887





13,922



Income from unconsolidated joint venture

(1,882)





(1,735)





(782)



Distributions from unconsolidated joint venture

3,030





2,665





750



Loss (gain) on sale of real estate, net

154





(165,977)





(37,802)



Loss (gain) on extinguishment of debt, net

21,646





(242)





11,192



Change in fair value of derivative financial instruments









(884)



Changes in operating assets and liabilities:











Receivables and other assets, net

(12,857)





(17,558)





(33,295)



Accounts payable and accrued liabilities

(128)





9,478





37,406



Prepaid rent and other liabilities

8,577





3,056





5,545



Net cash provided by operating activities

340,394





337,396





307,543



Cash flows from investing activities:











Investments in real estate

(553,298)





(17,389)





(2,383,581)



Investment in unconsolidated joint venture









(68,839)



Development of real estate

(28,066)





(34,270)





(25,191)



Proceeds from the sale of real estate

4,880





305,135





80,640



Capital expenditures

(91,544)





(77,870)





(64,833)



Collection of real estate notes receivable

739





703





9,964



Advances on real estate notes receivable









(3,256)



Net cash (used in) provided by investing activities

(667,289)





176,309





(2,455,096)



Cash flows from financing activities:











Borrowings on unsecured revolving credit facility

610,000





145,000





570,000



Payments on unsecured revolving credit facility

(510,000)





(145,000)





(658,000)



Proceeds from unsecured senior notes

906,927









900,000



Payments on unsecured senior notes

(700,000)











Payments on secured mortgage loans

(97,361)





(241,021)





(77,024)



Deferred financing costs

(7,776)





(782)





(16,904)



Debt extinguishment costs

(18,383)





(1,909)





(10,571)



Security deposits









2,419



Proceeds from issuance of common stock

323,393





72,814





1,746,956



Issuance of OP Units





411







Repurchase and cancellation of common stock

(12,178)





(70,319)





(3,413)



Dividends paid

(256,117)





(252,651)





(207,087)



Distributions paid to noncontrolling interest of limited partners

(8,758)





(5,278)





(5,308)



Sale of noncontrolling interest

1,234











Net cash provided by (used in) financing activities

230,981





(498,735)





2,241,068



Net change in cash, cash equivalents and restricted cash

(95,914)





14,970





93,515



Cash, cash equivalents and restricted cash - beginning of year

133,530





118,560





25,045



Cash, cash equivalents and restricted cash - end of year

$

37,616





$

133,530





$

118,560



 

HEALTHCARE TRUST OF AMERICA, INC.

NOI, CASH NOI AND SAME-PROPERTY CASH NOI

(Unaudited and in thousands)





Three Months Ended December 31,



Year Ended December 31,



2019



2018



2019



2018

Net income

$

9,036





$

15,605





$

30,758





$

217,626



General and administrative expenses

10,203





8,915





41,360





35,196



Transaction expenses

1,492





70





2,350





1,003



Depreciation and amortization expense

78,654





69,566





290,384





279,630



Impairment













8,887



Interest expense

24,031





24,457





96,632





101,849



Loss (gain) on sale of real estate, net

117





395





154





(165,977)



(Gain) loss on extinguishment of debt, net





(1,334)





21,646





(242)



Income from unconsolidated joint venture

(426)





(330)





(1,882)





(1,735)



Other income

(60)





(299)





(841)





(428)



NOI

$

123,047





$

117,045





$

480,561





$

475,809



NOI percentage growth

5.1

%







1.0

%





















NOI

$

123,047





$

117,045





$

480,561





$

475,809



Straight-line rent adjustments, net

(1,600)





(2,394)





(9,861)





(10,683)



Amortization of (below) and above market leases/leasehold interests, net and other GAAP adjustments

(394)





26





(1,534)





99



Notes receivable interest income

(21)





(30)





(96)





(131)



Cash NOI

$

121,032





$

114,647





$

469,070





$

465,094



Acquisitions not owned/operated for all periods presented and disposed properties Cash NOI

(5,078)





(31)





(10,278)





(14,175)



Redevelopment Cash NOI

308





(1,281)





(2,653)





(6,457)



Intended for sale Cash NOI

(1,330)





(1,242)





(5,227)





(5,606)



Same-Property Cash NOI (1)

$

114,932





$

112,093





$

450,912





$

438,856



Same-Property Cash NOI percentage growth

2.5

%







2.7

%







(1) Same-Property includes 410 and 405 buildings for the three months and year ended December 31, 2019 and 2018, respectively.

NOI is a non-GAAP financial measure that is defined as net income or loss (computed in accordance with GAAP) before: (i) general and administrative expenses; (ii) transaction expenses; (iii) depreciation and amortization expense; (iv) impairment; (v) interest expense; (vi) gain or loss on sales of real estate; (vii) gain or loss on extinguishment of debt; (viii) income or loss from unconsolidated joint venture; and (ix) other income or expense.  HTA believes that NOI provides an accurate measure of the operating performance of its operating assets because NOI excludes certain items that are not associated with the management of its properties.  Additionally, HTA believes that NOI is a widely accepted measure of comparative operating performance of real estate investment trusts ("REITs").  However, HTA's use of the term NOI may not be comparable to that of other REITs as they may have different methodologies for computing this amount.  NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of HTA's financial performance.  NOI should be reviewed in connection with other GAAP measurements.

Cash NOI is a non-GAAP financial measure which excludes from NOI: (i) straight-line rent adjustments; (ii) amortization of below and above market leases/leasehold interests and other GAAP adjustments; and (iii) notes receivable interest income.  Contractual base rent, contractual rent increases, contractual rent concessions and changes in occupancy or lease rates upon commencement and expiration of leases are a primary driver of HTA's revenue performance.  HTA believes that Cash NOI, which removes the impact of straight-line rent adjustments, provides another measurement of the operating performance of its operating assets.  Additionally, HTA believes that Cash NOI is a widely accepted measure of comparative operating performance of REITs.  However, HTA's use of the term Cash NOI may not be comparable to that of other REITs as they may have different methodologies for computing this amount.  Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of its financial performance.  Cash NOI should be reviewed in connection with other GAAP measurements.

To facilitate the comparison of Cash NOI between periods, HTA calculates comparable amounts for a subset of its owned and operational properties referred to as "Same-Property".  Same-Property Cash NOI excludes (i) properties which have not been owned and operated by HTA during the entire span of all periods presented and disposed properties, (ii) HTA's share of unconsolidated joint ventures, (iii) development, redevelopment and land parcels, (iv) properties intended for disposition in the near term which have (a) been approved by the Board of Directors, (b) are actively marketed for sale, and (c) an offer has been received at prices HTA would transact and the sales process is ongoing, and (v) certain non-routine items.  Same-Property Cash NOI should not be considered as an alternative to net income or loss (computed in accordance with GAAP) as an indicator of its financial performance.  Same-Property Cash NOI should be reviewed in connection with other GAAP measurements.

HEALTHCARE TRUST OF AMERICA, INC.

FFO, NORMALIZED FFO AND NORMALIZED FAD

(Unaudited and in thousands, except per share data)





Three Months Ended December 31,



Year Ended December 31,



2019



2018



2019



2018

Net income attributable to common stockholders

$

8,918





$

15,329





$

30,154





$

213,463



Depreciation and amortization expense related to investments in real estate

77,758





69,001





287,572





277,446



Loss (gain) on sale of real estate, net

117





395





154





(165,977)



Impairment













8,887



Proportionate share of joint venture depreciation and amortization

468





469





1,858





1,746



FFO attributable to common stockholders

$

87,261





$

85,194





$

319,738





$

335,565



Transaction expenses

1,492





70





2,350





859



(Gain) loss on extinguishment of debt, net





(1,334)





21,646





(242)



Noncontrolling income from OP units included in diluted shares

118





252





538





4,074



Other normalizing items, net













144



Normalized FFO attributable to common stockholders

$

88,871





$

84,182





$

344,272





$

340,400



Non-cash compensation expense

2,299





1,925





10,127





9,755



Straight-line rent adjustments, net

(1,600)





(2,394)





(9,861)





(10,683)



Amortization of (below) and above market leases/leasehold interests and corporate assets, net

(580)





592





(535)





2,401



Deferred revenue - tenant improvement related and other

(1)





(300)





(5)





(499)



Amortization of deferred financing costs and debt discount/premium, net

935





1,403





5,216





5,260



Recurring capital expenditures, tenant improvements and leasing commissions

(17,663)





(17,117)





(59,803)





(61,375)



Normalized FAD attributable to common stockholders

$

72,261





$

68,291





$

289,411





$

285,259



















Net income attributable to common stockholders per diluted share

$

0.04





$

0.07





$

0.14





$

1.02



FFO adjustments per diluted share, net

0.37





0.34





1.39





0.58



FFO attributable to common stockholders per diluted share

$

0.41





$

0.41





$

1.53





$

1.60



Normalized FFO adjustments per diluted share, net

0.01





(0.01)





0.11





0.02



Normalized FFO attributable to common stockholders per diluted share

$

0.42





$

0.40





$

1.64





$

1.62



















Weighted average diluted common shares outstanding

211,472





210,338





209,605





210,061



HTA computes FFO in accordance with the current standards established by NAREIT.  NAREIT defines FFO as net income or loss attributable to common stockholders (computed in accordance with GAAP), excluding gains or losses from sales of real estate property and impairment write-downs of depreciable assets, plus depreciation and amortization related to investments in real estate, and after adjustments for unconsolidated partnerships and joint ventures.  Because FFO excludes depreciation and amortization unique to real estate, among other items, it provides a perspective not immediately apparent from net income or loss attributable to common stockholders.

HTA computes Normalized FFO, which excludes from FFO: (i) transaction expenses; (ii) gain or loss on extinguishment of debt; (iii) noncontrolling income or loss from OP Units included in diluted shares; and (iv) other normalizing items, which include items that are unusual and infrequent in nature.  HTA's methodology for calculating Normalized FFO may be different from the methods utilized by other REITs and, accordingly, may not be comparable to other REITs.

HTA also computes Normalized FAD, which excludes from Normalized FFO: (i) non-cash compensation expense; (ii) straight-line rent adjustments; (iii) amortization of below and above market leases/leasehold interests and corporate assets; (iv) deferred revenue - tenant improvement related and other income; (v) amortization of deferred financing costs and debt premium/discount; and (vi) recurring capital expenditures, tenant improvements and leasing commissions.  HTA believes this non-GAAP financial measure provides a meaningful supplemental measure of its operating performance.  Normalized FAD should not be considered as an alternative to net income or loss attributable to common stockholders (computed in accordance with GAAP) as an indicator of its financial performance, nor is it indicative of cash available to fund cash needs.  Normalized FAD should be reviewed in connection with other GAAP measurements.

HTA presents these non-GAAP financial measures because it considers them important supplemental measures of its operating performance and believes they are frequently used by securities analysts, investors and other interested parties in the evaluation of REITs.  Historical cost accounting assumes that the value of real estate assets diminishes ratably over time.  Since real estate values have historically risen or fallen based on market conditions, many industry investors have considered the presentation of operating results for real estate companies that use historical cost accounting to be insufficient by themselves.  These non-GAAP financial measures should not be considered as alternatives to net income or loss attributable to common stockholders (computed in accordance with GAAP) as indicators of its financial performance.  FFO and Normalized FFO is not indicative of cash available to fund cash needs.  These non-GAAP financial measures should be reviewed in connection with other GAAP measurements.

HEALTHCARE TRUST OF AMERICA, INC.

NET DEBT TO ADJUSTED EBITDAre

(Unaudited and in thousands)





Three Months Ended



December 31, 2019

Net income

$

9,036

Interest expense

24,031

Depreciation and amortization expense

78,654

Loss on sale of real estate, net

117

Proportionate share of joint venture depreciation and amortization

468

EBITDAre

$

112,306

Transaction expenses

1,492

Non-cash compensation expense

2,299

Pro forma impact of acquisitions/dispositions

3,909

Adjusted EBITDAre

$

120,006





Adjusted EBITDAre, annualized

$

480,024





As of December 31, 2019:



Debt

$

2,749,775

Less: cash and cash equivalents

32,713

Net Debt

$

2,717,062





Net Debt to Adjusted EBITDAre

5.7x

As defined by NAREIT, EBITDAre is computed as net income or loss (computed in accordance with GAAP) plus: (i) interest expense; (ii) income tax expense (not applicable to HTA); (iii) depreciation and amortization; (iv) impairment; (v) gain or loss on the sale of real estate; and (vi) the proportionate share of joint venture depreciation and amortization.

Adjusted EBITDAre is presented on an assumed annualized basis.  HTA defines Adjusted EBITDAre as EBITDAre (computed in accordance with NAREIT as defined above) plus: (i) transaction expenses; (ii) gain or loss on extinguishment of debt; (iii) non-cash compensation expense; (iv) pro forma impact of its acquisitions/dispositions; and (v) other normalizing items.  HTA considers Adjusted EBITDAre an important measure because it provides additional information to allow management, investors, and its current and potential creditors to evaluate and compare its core operating results and its ability to service debt.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/healthcare-trust-of-america-inc-reports-2019-results-and-2020-earnings-guidance-301004899.html

SOURCE Healthcare Trust of America, Inc.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsPress ReleasesReal EstateBanking/Financial Servicescommercial real estateConference Call Announcements
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!